Literature DB >> 22796337

Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver.

Clinton M Hasenour1, Eric D Berglund, David H Wasserman.   

Abstract

This review summarizes the emerging role of AMP-activated protein kinase (AMPK) in mediating endocrine regulation of metabolic fluxes in the liver. There are a number of hormones which, when acting on the liver, alter AMPK activation. Here we describe those hormones associated with activation and de-activation of AMPK and the potential mechanisms for changes in AMPK activation state. The actions of these hormones, in many cases, are consistent with downstream effects of AMPK signaling thus strengthening the circumstantial case for AMPK-mediated hormone action. In recent years, genetic mouse models have also been used in an attempt to establish the role of AMPK in hormone-stimulated metabolism in the liver. Few experiments have, however, firmly established a causal relationship between hormone action at the liver and AMPK signaling.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796337      PMCID: PMC3538936          DOI: 10.1016/j.mce.2012.06.018

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  127 in total

1.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.

Authors:  A H Berg; T P Combs; X Du; M Brownlee; P E Scherer
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

2.  Energy state of the liver during short-term and exhaustive exercise in C57BL/6J mice.

Authors:  Raul C Camacho; E Patrick Donahue; Freyja D James; Eric D Berglund; David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-10-11       Impact factor: 4.310

3.  Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists.

Authors:  Andrea R Nawrocki; Michael W Rajala; Eva Tomas; Utpal B Pajvani; Asish K Saha; Myrna E Trumbauer; Zhen Pang; Airu S Chen; Neil B Ruderman; Howard Chen; Luciano Rossetti; Philipp E Scherer
Journal:  J Biol Chem       Date:  2005-12-02       Impact factor: 5.157

4.  The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin.

Authors:  Reuben J Shaw; Katja A Lamia; Debbie Vasquez; Seung-Hoi Koo; Nabeel Bardeesy; Ronald A Depinho; Marc Montminy; Lewis C Cantley
Journal:  Science       Date:  2005-11-24       Impact factor: 47.728

5.  The hormone resistin links obesity to diabetes.

Authors:  C M Steppan; S T Bailey; S Bhat; E J Brown; R R Banerjee; C M Wright; H R Patel; R S Ahima; M A Lazar
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

6.  Phosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowth.

Authors:  G P Sapkota; A Kieloch; J M Lizcano; S Lain; J S Arthur; M R Williams; N Morrice; M Deak; D R Alessi
Journal:  J Biol Chem       Date:  2001-01-31       Impact factor: 5.157

7.  Glucagon response to exercise is critical for accelerated hepatic glutamine metabolism and nitrogen disposal.

Authors:  M G Krishna; R H Coker; D B Lacy; B A Zinker; A E Halseth; D H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-09       Impact factor: 4.310

8.  The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes.

Authors:  R B Vega; J M Huss; D P Kelly
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

9.  Hepatocyte nuclear factor-4alpha involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase.

Authors:  I Leclerc; C Lenzner; L Gourdon; S Vaulont; A Kahn; B Viollet
Journal:  Diabetes       Date:  2001-07       Impact factor: 9.461

10.  Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485/491.

Authors:  Sandrine Horman; Didier Vertommen; Richard Heath; Dietbert Neumann; Véronique Mouton; Angela Woods; Uwe Schlattner; Theo Wallimann; David Carling; Louis Hue; Mark H Rider
Journal:  J Biol Chem       Date:  2005-12-09       Impact factor: 5.157

View more
  34 in total

1.  5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.

Authors:  Clinton M Hasenour; D Emerson Ridley; Curtis C Hughey; Freyja D James; E Patrick Donahue; Jane Shearer; Benoit Viollet; Marc Foretz; David H Wasserman
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

2.  Glucagon's effect on liver protein metabolism in vivo.

Authors:  Guillaume Kraft; Katie C Coate; Jason J Winnick; Dominique Dardevet; E Patrick Donahue; Alan D Cherrington; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-23       Impact factor: 4.310

3.  Trials and tribulations in drug development for nonalcoholic steatohepatitis.

Authors:  Arun J Sanyal; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-10       Impact factor: 11.382

Review 4.  Unraveling the actions of AMP-activated protein kinase in metabolic diseases: Systemic to molecular insights.

Authors:  Karen A Weikel; Neil B Ruderman; José M Cacicedo
Journal:  Metabolism       Date:  2016-01-14       Impact factor: 8.694

5.  Loss of hepatic AMP-activated protein kinase impedes the rate of glycogenolysis but not gluconeogenic fluxes in exercising mice.

Authors:  Curtis C Hughey; Freyja D James; Deanna P Bracy; E Patrick Donahue; Jamey D Young; Benoit Viollet; Marc Foretz; David H Wasserman
Journal:  J Biol Chem       Date:  2017-10-16       Impact factor: 5.157

6.  Cafeteria diet overfeeding in young male rats impairs the adaptive response to fed/fasted conditions and increases adiposity independent of body weight.

Authors:  H Castro; C A Pomar; C Picó; J Sánchez; A Palou
Journal:  Int J Obes (Lond)       Date:  2014-07-21       Impact factor: 5.095

7.  Analysis of aquaporin expression in liver with a focus on hepatocytes.

Authors:  Françoise Gregoire; Valério Lucidi; Amal Zerrad-Saadi; Myrna Virreira; Nargis Bolaky; Valérie Delforge; Arnaud Lemmers; Vincent Donckier; Jacques Devière; Pieter Demetter; Jason Perret; Christine Delporte
Journal:  Histochem Cell Biol       Date:  2015-07-01       Impact factor: 4.304

8.  Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice.

Authors:  Xiaoyi Qi; Yanjing Guo; Yongfeng Song; Chunxiao Yu; Lifang Zhao; Li Fang; Dehuan Kong; Jiajun Zhao; Ling Gao
Journal:  Diabetologia       Date:  2018-02-13       Impact factor: 10.122

9.  Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver.

Authors:  Santhosh Satapati; Blanka Kucejova; Joao A G Duarte; Justin A Fletcher; Lacy Reynolds; Nishanth E Sunny; Tianteng He; L Arya Nair; Kenneth A Livingston; Kenneth Livingston; Xiaorong Fu; Matthew E Merritt; A Dean Sherry; Craig R Malloy; John M Shelton; Jennifer Lambert; Elizabeth J Parks; Ian Corbin; Mark A Magnuson; Jeffrey D Browning; Shawn C Burgess
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

10.  A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen.

Authors:  Anaïs Michaut; Dounia Le Guillou; Caroline Moreau; Simon Bucher; Mitchell R McGill; Sophie Martinais; Thomas Gicquel; Isabelle Morel; Marie-Anne Robin; Hartmut Jaeschke; Bernard Fromenty
Journal:  Toxicol Appl Pharmacol       Date:  2015-12-29       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.